Detalhe da pesquisa
1.
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer.
Int J Cancer
; 146(8): 2348-2359, 2020 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31490549
2.
Facts and Hopes in Immunotherapy for Early-Stage Triple-Negative Breast Cancer.
Clin Cancer Res
; 29(13): 2362-2370, 2023 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36622327
3.
Immune landscape of breast tumors with low and intermediate estrogen receptor expression.
NPJ Breast Cancer
; 9(1): 39, 2023 May 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37179445
4.
IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer.
Cancer Cell
; 41(1): 106-123.e10, 2023 01 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36525971
5.
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial.
Nat Cancer
; 4(4): 535-549, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37038006
6.
LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer.
Nat Cancer
; 3(3): 355-370, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35301507
7.
Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer.
Cancers (Basel)
; 13(16)2021 Aug 17.
Artigo
Inglês
| MEDLINE | ID: mdl-34439290
8.
Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers.
Sci Transl Med
; 13(617): eabe6201, 2021 Oct 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34705519
9.
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer.
Nat Commun
; 12(1): 5668, 2021 09 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34580291
10.
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
NPJ Breast Cancer
; 6: 15, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32436923
11.
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
NPJ Breast Cancer
; 6: 16, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32411818
12.
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
NPJ Breast Cancer
; 6: 17, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32411819
13.
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.
Nat Med
; 25(6): 920-928, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31086347
14.
Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.
Nat Med
; 25(7): 1175, 2019 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-31209337